Cytiva Official site

Paul Laboratory Manifold

A laboratory manifold suitable for microbial testing using the membrane filter method - easy installation and all parts are sterilized.

The "Paul Laboratory Manifold" can be easily disassembled and assembled without the use of tools, making disinfection and sterilization straightforward. It is made of 316L stainless steel, providing chemical resistance, and all parts are sterilizable. It can be operated regardless of whether you are right-handed or left-handed, allowing for changes in installation location and suction direction. You can combine two three-way manifolds to use them as a six-way manifold. 【Features】 - Easy disassembly and assembly without tools, facilitating disinfection and sterilization - Operable regardless of right or left-handedness - Chemical resistance due to 316L stainless steel construction - Designed to prevent burping and backflow, ensuring a cleaner workspace - Various filter funnels can be used simply by swapping out the adapter - Two three-way manifolds can be combined to function as a six-way manifold *For more details, please refer to the PDF document or feel free to contact us.

Related Link - https://products.pall.jp/jp/ja/laboratory/microbio…

basic information

【Size of 3-way Stainless Steel Manifold】 ■Length: 437.1 mm ■Width: 152.4 mm ■Height: 99 mm ■Weight: 1.71 kg *For more details, please refer to the PDF document or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

【Application】 ■ The measurement of the viable count of water-soluble samples using the MF method is useful for monitoring and quality control of non-sterile pharmaceuticals, drinking water, wastewater, etc. * For more details, please refer to the PDF document or feel free to contact us.

Recommended products

Distributors

Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.